Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the detailed record of transactions filed by Shovlin Robert J., Président des Services Cliniques. Officer active across 1 company, notably Neogenomics INC. Aggregated, 1 reports have been recorded. History available since 25 May 2021. The latest transaction was disclosed on 25 May 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
Robert J. Shovlin is the President of Clinical Services at Neogenomics Inc. He leads the company's clinical operations, ensuring efficiency and quality of services. His expertise in biotechnology is crucial for developing innovative health solutions.